HCC-PULSAR: PULSAR Radiotherapy Combined With Immunotherapy for High-Risk Advanced Liver Cancer (clinicaltrials.gov) - Oct 21, 2026 - P2 | N=38 | Recruiting | Sponsor: Samsung Medical Center
New P2 trial • Hepatocellular Cancer • Liver Cancer • Oncology • Solid Tumor
|